Leaflet SEASONIQUE 150mcg / 30mcg / 10mcg film-coated tablets


Indicated for: contraception

Substance: levonorgestrel + ethinylestradiol (progestogen + estrogen)

ATC: G03AA07 (Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations)

The combination of levonorgestrel and ethinylestradiol is used as an oral contraceptive to prevent pregnancy. Levonorgestrel is a progestin, and ethinylestradiol is an estrogen, both working to inhibit ovulation and alter the uterine lining.

The medication is taken orally, usually once daily at the same time, following a 21- or 28-day cycle. It is important to adhere to the administration schedule to ensure contraceptive effectiveness.

Side effects may include nausea, headaches, breast tenderness, or mood changes. In rare cases, severe reactions such as venous thromboembolism may occur.

This combination is not recommended for pregnant women, breastfeeding mothers, or patients with a history of thrombosis, severe liver disease, or hypersensitivity to any of the components.

General data about SEASONIQUE 150mcg / 30mcg / 10mcg

  • Substance: levonorgestrel + ethinylestradiol
  • Date of last drug list: 01-05-2026
  • Commercial code: W61877001
  • Concentration: 150mcg / 30mcg / 10mcg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 84
  • Product type: original
  • Price: 121.97 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: TEVA OPERATIONS POLAND SP. Z.O.O. - POLONIA
  • Holder: THERAMEX IRELAND LIMITED - IRLANDA
  • Number: 12865/2019/01
  • Shelf life: 3 years

Pharmaceutical forms available for levonorgestrel + ethinylestradiol

Concentrations available for levonorgestrel + ethinylestradiol

  • 0.05mg/0.03mg
  • 0.15mg/0.03mg
  • 125mcg/30mcg
  • 150mcg/30mcg
  • 150mcg/30mcg/10mcg